share_log

Armata Pharmaceuticals Q3 EPS $(0.86) Misses $(0.31) Estimate, Sales $1.23M Beat $950.00K Estimate

Armata Pharmaceuticalsの第3四半期EPSは$(0.86)で、$(0.31)の推定値を下回り、売上は$ 1.23Mで、 $ 950.00Kの推定値を上回りました

Benzinga ·  2023/11/14 16:05

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.31) by 177.42 percent. This is a 258.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.23 million which beat the analyst consensus estimate of $950.00 thousand by 28.95 percent. This is a 8.45 percent decrease over sales of $1.34 million the same period last year.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする